Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
29.57
-0.37 (-1.24%)
At close: Oct 29, 2025, 4:00 PM EDT
29.57
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
Omnicell Market Cap
Omnicell has a market cap or net worth of $1.36 billion as of October 29, 2025. Its market cap has decreased by -30.71% in one year.
Market Cap
1.36B
Enterprise Value
1.34B
1-Year Change
-30.71%
Ranking
Category
Stock Price
$29.57
Market Cap Chart
Since August 9, 2001, Omnicell's market cap has increased from $181.10M to $1.36B, an increase of 650.01%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.38B | -33.30% |
| Dec 31, 2024 | 2.06B | 20.51% |
| Dec 29, 2023 | 1.71B | -24.00% |
| Dec 30, 2022 | 2.25B | -71.61% |
| Dec 31, 2021 | 7.93B | 56.15% |
| Dec 31, 2020 | 5.08B | 48.16% |
| Dec 31, 2019 | 3.43B | 41.23% |
| Dec 31, 2018 | 2.43B | 31.91% |
| Dec 29, 2017 | 1.84B | 48.60% |
| Dec 30, 2016 | 1.24B | 12.43% |
| Dec 31, 2015 | 1.10B | -6.62% |
| Dec 31, 2014 | 1.18B | 29.70% |
| Dec 31, 2013 | 909.20M | 84.27% |
| Dec 31, 2012 | 493.40M | -10.09% |
| Dec 30, 2011 | 548.80M | 15.22% |
| Dec 31, 2010 | 476.30M | 27.66% |
| Dec 31, 2009 | 373.10M | -2.41% |
| Dec 31, 2008 | 382.30M | -58.83% |
| Dec 31, 2007 | 928.70M | 77.54% |
| Dec 29, 2006 | 523.10M | 66.86% |
| Dec 30, 2005 | 313.50M | 12.69% |
| Dec 31, 2004 | 278.20M | -26.34% |
| Dec 31, 2003 | 377.70M | 547.86% |
| Dec 31, 2002 | 58.30M | -69.70% |
| Dec 31, 2001 | 192.40M | 6.24% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |